Article Text

Download PDFPDF
A pilot study on the use of a perfluorohexyloctane/silicone oil solution as a heavier than water internal tamponade agent
  1. D Wong1,
  2. J C Van Meurs2,
  3. T Stappler1,
  4. C Groenewald1,
  5. I A Pearce1,
  6. J N McGalliard1,*,
  7. E Manousakis1,
  8. E N Herbert1
  1. 1St Paul’s Eye Unit, Royal Liverpool University Hospital, Prescot Street, Liverpool L7 8XP, UK
  2. 2The Rotterdam Eye Hospital, Schiedamsevest 180, 3011 BH, Rotterdam, Netherlands
  1. Correspondence to: Mr David Wong St Paul’s Eye Unit, Royal Liverpool University Hospital, Prescot Street, Liverpool L7 8XP, UK; shdwongliv.ac.uk

Abstract

Aims: To report a prospective two centred non-comparative interventional pilot study of a solution of perfluorohexyloctane and silicone oil (Densiron-68) as a heavier than water internal tamponade.

Methods: 42 consecutive patients were recruited. The indications include proliferative vitreoretinopathy, retinal detachments arising from inferior retinal breaks, and inability to posture.

Results: The success rate with one operation using Densiron was 81% and with further surgery 93%. At the end of the study all tamponade agents were removed in 90% of patients. Visual acuity improved from mean logMAR of 1.41 (SD 0.64) to 0.94 (SD 0.57), p = 0.001. There was little evidence of dispersion and excessive inflammation.

Conclusion: This new tamponade agent is being compared to conventional silicone oil in a prospective international randomised trial.

  • ERM, epiretinal membranes
  • PFCL, perfluorocarbon liquids
  • PPV, pars plana vitrectomy
  • PVR, proliferative vitreoretinopathy
  • RD, retinal detachments
  • SiO, silicone oil
  • perfluorohexyloctane
  • silicone oil
  • proliferative vitreoretinopathy
  • retinal detachment
  • ERM, epiretinal membranes
  • PFCL, perfluorocarbon liquids
  • PPV, pars plana vitrectomy
  • PVR, proliferative vitreoretinopathy
  • RD, retinal detachments
  • SiO, silicone oil
  • perfluorohexyloctane
  • silicone oil
  • proliferative vitreoretinopathy
  • retinal detachment

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Footnotes

  • * Deceased.

  • The authors have no financial interest in the product Densiron.

Linked Articles